Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

VB-201, an oxidized phospholipid small molecule, inhibits CD14- and Toll-like receptor-2-dependent innate cell activation and constrains atherosclerosis.

Mendel I, Feige E, Yacov N, Salem Y, Levi I, Propheta-Meiran O, Shoham A, Ishai E, George J, Harats D, Breitbart E.

Clin Exp Immunol. 2014 Jan;175(1):126-37. doi: 10.1111/cei.12212.

2.
3.

Inhibition of monocyte chemotaxis by VB-201, a small molecule lecinoxoid, hinders atherosclerosis development in ApoE⁻/⁻ mice.

Feige E, Yacov N, Salem Y, Levi I, Mendel I, Propheta-Meiran O, Shoham A, Hait-Darshan R, Polonsky O, George J, Harats D, Breitbart E.

Atherosclerosis. 2013 Aug;229(2):430-9. doi: 10.1016/j.atherosclerosis.2013.06.005. Epub 2013 Jun 21.

4.

Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever.

Azeredo EL, Neves-Souza PC, Alvarenga AR, Reis SR, Torrentes-Carvalho A, Zagne SM, Nogueira RM, Oliveira-Pinto LM, Kubelka CF.

Immunology. 2010 Jun;130(2):202-16. doi: 10.1111/j.1365-2567.2009.03224.x. Epub 2010 Jan 27.

5.

Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns.

Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zügel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A.

Eur J Immunol. 2006 Feb;36(2):361-70.

6.

Treatment with Oxidized Phospholipids Directly Inhibits Nonalcoholic Steatohepatitis and Liver Fibrosis Without Affecting Steatosis.

Mendel I, Yacov N, Shoham A, Ishai E, Breitbart E.

Dig Dis Sci. 2016 Sep;61(9):2545-53. doi: 10.1007/s10620-016-4159-5. Epub 2016 Apr 13.

7.

Atherosclerotic lesion development and Toll like receptor 2 and 4 responsiveness.

Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G.

Atherosclerosis. 2008 Mar;197(1):95-104. Epub 2007 Sep 21.

PMID:
17888930
8.

The activation of CD14, TLR4, and TLR2 by mmLDL induces IL-1β, IL-6, and IL-10 secretion in human monocytes and macrophages.

Chávez-Sánchez L, Chávez-Rueda K, Legorreta-Haquet MV, Zenteno E, Ledesma-Soto Y, Montoya-Díaz E, Tesoro-Cruz E, Madrid-Miller A, Blanco-Favela F.

Lipids Health Dis. 2010 Oct 14;9:117. doi: 10.1186/1476-511X-9-117.

9.

Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response.

Chávez-Sánchez L, Madrid-Miller A, Chávez-Rueda K, Legorreta-Haquet MV, Tesoro-Cruz E, Blanco-Favela F.

Hum Immunol. 2010 Aug;71(8):737-44. doi: 10.1016/j.humimm.2010.05.005. Epub 2010 May 13.

PMID:
20472010
10.

Identification of soluble CD14 as an endogenous agonist for Toll-like receptor 2 on human astrocytes by genome-scale functional screening of glial cell derived proteins.

Bsibsi M, Bajramovic JJ, Van Duijvenvoorden E, Persoon C, Ravid R, Van Noort JM, Vogt MH.

Glia. 2007 Apr 1;55(5):473-82.

PMID:
17205552
11.

Toll-like receptor 3 and 4 signalling through the TRIF and TRAM adaptors in haematopoietic cells promotes atherosclerosis.

Lundberg AM, Ketelhuth DF, Johansson ME, Gerdes N, Liu S, Yamamoto M, Akira S, Hansson GK.

Cardiovasc Res. 2013 Jul 15;99(2):364-73. doi: 10.1093/cvr/cvt033. Epub 2013 Feb 14.

PMID:
23417039
12.

Oxidized LDLs inhibit TLR-induced IL-10 production by monocytes: a new aspect of pathogen-accelerated atherosclerosis.

Bzowska M, Nogieć A, Skrzeczyńska-Moncznik J, Mickowska B, Guzik K, Pryjma J.

Inflammation. 2012 Aug;35(4):1567-84. doi: 10.1007/s10753-012-9472-3.

13.

Lgr4/Gpr48 negatively regulates TLR2/4-associated pattern recognition and innate immunity by targeting CD14 expression.

Du B, Luo W, Li R, Tan B, Han H, Lu X, Li D, Qian M, Zhang D, Zhao Y, Liu M.

J Biol Chem. 2013 May 24;288(21):15131-41. doi: 10.1074/jbc.M113.455535. Epub 2013 Apr 15.

14.

Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies.

Satta N, Kruithof EK, Fickentscher C, Dunoyer-Geindre S, Boehlen F, Reber G, Burger D, de Moerloose P.

Blood. 2011 May 19;117(20):5523-31. doi: 10.1182/blood-2010-11-316158. Epub 2011 Feb 17.

15.

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.

Arthritis Rheum. 2004 May;50(5):1457-67.

16.
17.

Differential roles of CD14 and toll-like receptors 4 and 2 in murine Acinetobacter pneumonia.

Knapp S, Wieland CW, Florquin S, Pantophlet R, Dijkshoorn L, Tshimbalanga N, Akira S, van der Poll T.

Am J Respir Crit Care Med. 2006 Jan 1;173(1):122-9. Epub 2005 Oct 6.

PMID:
16210672
18.

The roles of Toll-like receptors in atherosclerosis.

Erridge C.

J Innate Immun. 2009;1(4):340-9. doi: 10.1159/000191413. Epub 2009 Jan 8. Review.

19.

TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness.

Graveline R, Segura M, Radzioch D, Gottschalk M.

Int Immunol. 2007 Apr;19(4):375-89. Epub 2007 Feb 16.

PMID:
17307800
20.

Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.

Wong-Baeza C, Tescucano A, Astudillo H, Reséndiz A, Landa C, España L, Serafín-López J, Estrada-García I, Estrada-Parra S, Flores-Romo L, Wong C, Baeza I.

J Immunol Res. 2015;2015:369462. doi: 10.1155/2015/369462. Epub 2015 Oct 19.

Supplemental Content

Support Center